PRO-DEX, INC. Operating Lease Liability
PRO-DEX, INC. (PDEX) had Operating Lease Liability of $1.68 million as of 2026-03-31, per its 10-Q filed 2026-04-30.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-04-30
- 2026-03-31: Operating Lease, Liability $1.68M.
- 2025-12-31: Operating Lease, Liability $939.00K.
- 2025-09-30: Operating Lease, Liability $1.06M.
- 2025-03-31: Operating Lease, Liability $1.30M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-03-31 | $1.68M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $939.00K 10-Q · filed 2026-01-29 |
| 2025-09-30 | $1.06M 10-Q · filed 2025-10-30 |
| 2025-03-31 | $1.30M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $1.42M 10-Q · filed 2025-01-30 |
| 2024-09-30 | $1.53M 10-Q · filed 2024-10-31 |
| 2024-03-31 | $1.75M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $1.85M 10-Q · filed 2024-02-08 |
| 2023-09-30 | $1.96M 10-Q · filed 2023-11-02 |
| 2023-03-31 | $2.15M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $2.25M 10-Q · filed 2023-02-02 |
| 2022-09-30 | $2.34M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $2.43M 10-K · filed 2022-09-08 |
| 2022-03-31 | $2.52M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $2.61M 10-Q · filed 2022-02-03 |
| 2021-09-30 | $2.69M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $2.78M 10-K · filed 2021-09-09 |
| 2021-03-31 | $2.86M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $2.94M 10-Q · filed 2021-02-04 |
| 2020-09-30 | $3.02M 10-Q · filed 2020-11-05 |
| 2020-03-31 | $3.16M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $3.23M 10-Q · filed 2020-02-06 |
| 2019-09-30 | $3.30M 10-Q · filed 2019-11-07 |
| 2019-07-01 | $3.30M 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |